Jeevan Patra | Drug Design | Best Researcher Award

Best Researcher Award

Jeevan Patra
National Institute of Technology, Rourkela

Jeevan Patra
Affiliation National Institute of Technology, Rourkela
Country India
Scholar ID n3bgLpAAAAAJ
Documents 35
Citations 323
h-index 6
Subject Area Drug Design
Event Global Academic Awards
ORCID 0000-0002-2709-4268

Jeevan Patra, a researcher affiliated with the National Institute of Technology, Rourkela, India. The profile summarizes publicly available academic indicators, research specialization, scholarly contributions, publication performance, and recognition within the field of Drug Design. The article follows a neutral, encyclopedia-inspired presentation intended for academic recognition and reference.[1]

Abstract

Jeevan Patra has developed research interests centered on Drug Design and associated interdisciplinary biomedical sciences. Available scholarly indicators demonstrate sustained publication activity supported by peer-reviewed research outputs and measurable citation impact. The profile illustrates an active contribution to scientific literature and highlights engagement with contemporary pharmaceutical and molecular research topics.[1][2]

Keywords

Drug Design, Computational Drug Discovery, Medicinal Chemistry, Pharmaceutical Research, Molecular Modeling, Bioinformatics, Chemical Biology, Structure-Based Drug Design, Academic Research, Scientific Publications.

Introduction

Drug Design represents an essential research discipline supporting the discovery and optimization of therapeutic compounds through experimental and computational methodologies. Researchers working in this area contribute to advances in medicinal chemistry, molecular pharmacology, and pharmaceutical development. Academic performance is commonly evaluated through publication records, citation metrics, collaboration networks, and contributions to innovation.[3]

Research Profile

Jeevan Patra is affiliated with the National Institute of Technology, Rourkela, India. Publicly available scholarly metrics indicate approximately 35 indexed research documents with more than 323 citations and an h-index of 6. These indicators reflect continued participation in scholarly publishing and ongoing contributions to research related to Drug Design and associated biomedical disciplines.[1]

Research Contributions

The available publication record demonstrates involvement in multidisciplinary investigations supporting pharmaceutical innovation, computational chemistry, molecular interactions, and drug discovery strategies. Research contributions emphasize scientific rigor, peer-reviewed dissemination, and collaboration across complementary scientific domains.[2]

  • Drug discovery methodologies.
  • Medicinal chemistry research.
  • Computational molecular analysis.
  • Scientific collaboration and publication.

Publications

The research portfolio consists of peer-reviewed journal publications indexed by major scholarly databases. Publications collectively demonstrate continuing academic engagement in pharmaceutical sciences and computational approaches for therapeutic development.[2]

  • Approximately 35 scholarly publications.
  • Citation count exceeding 323.
  • Research indexed within recognized academic databases.

Research Impact

Citation metrics and publication activity indicate measurable scholarly visibility within the Drug Design research community. Citation-based indicators, together with publication consistency, suggest that the research has contributed to ongoing scientific discussions and knowledge development in pharmaceutical sciences.[1]

Award Suitability

Based on publicly available scholarly indicators, Jeevan Patra demonstrates characteristics commonly considered during academic recognition processes, including peer-reviewed publications, citation performance, research productivity, and contributions within the field of Drug Design. Final award decisions remain dependent upon the formal evaluation criteria established by the Global Academic Awards and supporting documentation submitted by the nominee.[4]

Conclusion

The academic profile presented here summarizes available bibliometric information together with an overview of scholarly activities in Drug Design. Through peer-reviewed publications, citation performance, and institutional affiliation, the profile reflects sustained participation in scientific research while providing an objective reference suitable for academic recognition documentation.[1]

References

  1. Google Scholar. (n.d.). Scholar profile: Jeevan Patra.
    https://scholar.google.com/citations?user=n3bgLpAAAAAJ&hl=en
  2. Crossref DOI Foundation. (n.d.). Digital Object Identifier System.
    https://doi.org/10.1038/nrd.2017.203
  3. Computational Design of Pyrazole Derivatives for Management of Autoimmune Disease. https://link.springer.com/chapter/10.1007/978-3-032-12320-6_8
  4. Global Academic Awards. (n.d.). Award nomination information.
    https://globalacademicawards.com/

Jaber Salehzadeh | Organic Synthesis | Research Excellence Award

Research Excellence Award

Jaber Salehzadeh
Provincial Water and Sewage Company, Iran

Jaber Salehzadeh
Affiliation Provincial Water and Sewage Company
Country Iran
Scholar ID fhaf0jMAAAAJ
Documents 24
Citations 310
h-index 9
Subject Area Organic Synthesis
Event Global Academic Awards

Jaber Salehzadeh has established an academic profile supported by publications, citations, and interdisciplinary research interests. Although affiliated with the Provincial Water and Sewage Company, the available scholarly record indicates research activity relevant to Organic Synthesis and related scientific applications. The available Google Scholar metrics indicate an active publication history with twenty-four documents, more than three hundred citations, and an h-index of nine.[1]

Abstract

Jaber Salehzadeh is a researcher associated with the Provincial Water and Sewage Company in Iran. According to the publicly available Google Scholar profile, the researcher has produced twenty-four scholarly publications that have collectively received more than three hundred citations, resulting in an h-index of nine. The documented publication record reflects continued scientific engagement in Organic Synthesis and associated interdisciplinary research areas, demonstrating a measurable academic presence through peer-reviewed research and scholarly dissemination.[1]

Keywords

Organic Synthesis, Synthetic Chemistry, Chemical Research, Reaction Engineering, Molecular Design, Green Chemistry, Scientific Publications, Research Excellence, Chemical Innovation, Academic Recognition.

Introduction

Organic Synthesis remains one of the foundational disciplines within modern chemistry, supporting discoveries across pharmaceuticals, materials science, catalysis, agriculture, and environmental technologies. Advances in synthetic methodologies continue to improve reaction efficiency, molecular complexity, sustainability, and industrial scalability. Researchers working in this field contribute to expanding chemical knowledge through innovative reaction pathways, characterization techniques, and practical applications that influence numerous scientific disciplines.[2]

Research Profile

The publicly available Google Scholar profile indicates that Jaber Salehzadeh has established a sustained publication record with twenty-four indexed scholarly works receiving approximately three hundred ten citations. The resulting h-index of nine reflects consistent citation activity across multiple publications. These indicators demonstrate continuing scholarly participation and measurable academic visibility within the research community.[1]

  • Affiliation: Provincial Water and Sewage Company
  • Country: Iran
  • Google Scholar Publications: 24
  • Total Citations: 310
  • h-index: 9

Research Contributions

The available scholarly profile suggests contributions involving Organic Synthesis and chemically related research. Research in this area commonly supports the development of efficient synthetic strategies, improved catalytic systems, environmentally responsible reaction processes, and the preparation of compounds with potential scientific and industrial significance. Such work contributes to expanding the broader knowledge base of modern chemistry.[2]

Publications

The documented publication portfolio demonstrates continued scholarly productivity through peer-reviewed research articles. Citation activity indicates that the published work has been referenced by other researchers, providing evidence of academic engagement and contribution to ongoing scientific discussions within chemistry and related disciplines.[1]

  • Twenty-four documented scholarly publications.
  • Research involving Organic Synthesis and related chemical sciences.
  • Peer-reviewed scientific dissemination supporting ongoing academic research.

Research Impact

Citation metrics provide quantitative evidence of scholarly influence. With approximately three hundred ten citations and an h-index of nine, the available academic indicators demonstrate that the published work has received recognition within the scientific community. These metrics represent measurable research visibility and continuing academic relevance.[1]

Award Suitability

Based on the documented scholarly metrics and publication record, Jaber Salehzadeh demonstrates characteristics frequently considered during academic recognition programs, including sustained research productivity, measurable citation performance, and continued scientific contributions. These documented achievements support consideration for the Research Excellence Award presented through the Global Academic Awards while acknowledging that award decisions depend upon the complete evaluation criteria established by the organizing committee.[1]

Conclusion

Jaber Salehzadeh has developed a documented scholarly profile characterized by peer-reviewed publications, measurable citation impact, and continued engagement in Organic Synthesis research. The available publication metrics demonstrate sustained academic participation and an established record of scientific contribution. Continued research productivity and scholarly collaboration are expected to further strengthen future academic impact within the broader chemical sciences community.[1]

References

  1. Google Scholar. (n.d.). Scholar profile: Jaber Salehzadeh, Scholar ID fhaf0jMAAAAJ.
    https://scholar.google.com/citations?user=fhaf0jMAAAAJ&hl=en&oi=sra
  2. Carey, F. A., & Sundberg, R. J. Advanced Organic Chemistry.
    DOI: https://doi.org/10.1007/978-0-387-44899-2
  3. A study on fractality properties of nano particles scanning electron microscopy images
    https://ljs.academicdirect.org/A25/111_116.htm

Ulises Martinez Ortega | Medicinal Chemistry | Young Scientist Award

Dr. Ulises Martinez Ortega | Medicinal Chemistry | Young Scientist Award

Professor | National Autonomous University of Mexico | Mexico

Dr. Ulises Martinez-Ortega’s research focuses on computational chemistry, molecular modeling, and drug design, particularly targeting cancer-related pathways such as EGFR inhibition. With 3 publications, 11 citations across 11 documents, and an h-index of 2, his work contributes to the development of quinazoline-based compounds with therapeutic potential. He applies advanced computational techniques, including free energy calculations, to optimize molecular interactions. His research supports the discovery of efficient, targeted treatments and advances understanding in medicinal chemistry and pharmaceutical development.

Citation Metrics (Scopus)

12

10

8

6

4

2

0

Citations
11

Documents
3

h-index
2

        🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Profile
View ORCID Profile
View Google Scholar Profile

Featured Publications

Alchemical Free Energy-Based Optimization of Quinazoline Derivatives as Potent EGFR Inhibitors with Cytotoxic Activity
– Bioorganic and Medicinal Chemistry, 2025

Computational Design and Evaluation of Quinazoline-Based Compounds for Targeted Cancer Therapy
– Medicinal Chemistry Research

Molecular Modeling and Drug Design Approaches for EGFR Inhibitors in Cancer Treatment
– Journal of Molecular Modeling

Siva Hariprasad Kurma | Chemistry | Research Excellence Award

Dr. Siva Hariprasad Kurma | Chemistry | Research Excellence Award

Dr. Siva Hariprasad Kurma is an NIH Postdoctoral Fellow specializing in synthetic methodologies and medicinal chemistry. He has published 20+ peer-reviewed articles with 242 citations, an h-index of 10, and strong impact since 2021. His research spans antimalarial drug design, heterocyclic synthesis, catalysis, and molecular modeling, contributing significantly to therapeutic chemistry and bioactive molecule development.

Citation Metrics (Google Scholar)

250

200

150

100

50

0

Citations
242

Documents
20

h-index
10

Citations
Documents
h-index


View Google Scholar Profile

Featured Publications

Dieter E. Kaufmann | Medicinal Chemistry | Best Researcher Award

Prof. Dr. Dieter E. Kaufmann | Medicinal Chemistry | Best Researcher Award

Technical University of Clausthal | Germany

Prof. Dr. Dieter E. Kaufmann is a distinguished organic chemist whose research bridges fundamental synthetic chemistry and applied materials science. His work focuses on the design and synthesis of heterocyclic compounds, polyhalogenated nitrobutadienes, and functionalized benzoates with applications in medicinal chemistry, sustainable materials, and energy systems. He has contributed extensively to the chemical modification of renewable resources, including wood, for enhanced durability, hydrophobicity, and flame retardancy, as well as to the development of organic redox flow batteries. With over 128 publications, 3,676 citations, and an h-index of 30, his research demonstrates high scientific impact, innovation, and interdisciplinary collaboration across organic synthesis, catalysis, and green chemistry.

Profile: Scopus | Orcid 

Featured Publications

  • Kaufmann, D. E., et al. (2025). Synthesis and microbiological activities of 3-nitropyrazolo-[1,5-d][1,2,4]triazin-7(6H)-ones and derivatives. Molecules, 2025.

  • Kaufmann, D. E., et al. (2025). Synthesis, characterization and application of thioindigosulfonic acids as electrolytes in an aqueous organic redox flow battery. ChemElectroChem, 2025.

  • Kaufmann, D. E., et al. (2023). A new way to 2,3,4-trisubstituted benzo[h]quinolines: Synthesis, consecutive reactions and cellular activities. Molecules, 2023.

  • Kaufmann, D. E., et al. (2023). Chemistry of polyhalogenated nitrobutadienes, 19: Synthesis of new types of compounds modulating the biological activity of Type I interferons (IFN-I). Arkivoc, 2023.

  • Kaufmann, D. E., et al. (2022). Intramolecular phosphine-promoted Knoevenagel based redox-reaction. Molecules, 2022.

  • Kaufmann, D. E., et al. (2022). Chemistry of polyhalogenated nitrobutadienes, 17: Efficient synthesis of persubstituted chloroquinolinyl-1H-pyrazoles and evaluation of their antimalarial, anti-SARS-CoV-2, antibacterial, and cytotoxic activities. Beilstein Journal of Organic Chemistry, 2022.

  • Kaufmann, D. E., et al. (2021). Surface tuning of wood via covalent modification of its lignocellulosic biopolymers with substituted benzoates: A study on reactivity, efficiency, and durability. ACS Omega, 2021.

  • Kaufmann, D. E., et al. (2021). Durable modification of wood by benzoylation—Proof of covalent bonding by solution state NMR and DOSY NMR quick-test. Polymers, 2021.

  • Kaufmann, D. E., et al. (2021). Chemical improvement of surfaces. Part 6: Enhanced flame retardancy of Scots pine sapwood by covalent modification with phosphorus and boron functionalized benzoates. Holzforschung, 2021.

  • Kaufmann, D. E., et al. (2021). Surface tuning of wood through chemical modification for enhanced performance and stability. Holzforschung, 2021.

Manisha Bansal | Medicinal Research | Best Researcher Award

Assist. Prof. Dr. Manisha Bansal | Medicinal Research | Best Researcher Award

Punjabi University Patiala | India

Assist. Prof. Dr. Manisha Bansal serves as Assistant Professor (Stage III) in the Department of Chemistry, Punjabi University, Patiala, India. She holds a Ph.D. in Synthetic and Medicinal Chemistry with a thesis on antihypertensive agents and has over 17 years of teaching and 15 years of research experience. Her expertise lies in synthetic organic chemistry, medicinal chemistry, and photochemistry, with extensive work in drug design, molecular modeling, and bioactive compound synthesis. Assist. Prof. Dr. Manisha Bansal has published 20 research papers, accumulating 92 citations and an h-index of 6, with publications in reputed journals like Molecular Diversity, Bioorganic Chemistry, and Journal of Biomolecular Structure and Dynamics. She has guided multiple M.Phil. and Ph.D. scholars, presented at numerous national and international conferences, and contributed as a reviewer for leading journals. Her current research explores multi-targeted drug design against inflammatory, microbial, and cancer pathways.

Profile: ScopusOrcid | Google Scholar

Featured Publications

1. Jain, R., & Bansal, M. (1995). A fascile synthesis and central nervous system activities of fluorine containing spiro-[3H-indole-3, 4′(4H)-pyran]-2 (1H)-ones. Pharmazie, 50(3), 224–225. (Cited by 18)

2. Kaur, G., Kaur, M., Sharad, L., & Bansal, M. (2020). Theoretical molecular predictions and antimicrobial activities of newly synthesized molecular hybrids of norfloxacin and ciprofloxacin. Journal of Heterocyclic Chemistry, 57(1), 225–237. (Cited by 13)

3. Bansal, M., & Kaur, R. (2015). Electromeric effect of substitution at 6th position in 2-(Furan-2-yl)-3-hydroxy-4H-chromen-4-one (FHC) on the absorption and emission spectra. Journal of Chemical Sciences, 127(3), 405–412. (Cited by 13)

4. Kaur, M., Rehman, H. M., Kaur, G., Kaur, A., & Bansal, M. (2023). Switching of newly synthesized linker-based derivatives of non-steroidal anti-inflammatory drugs toward anti-inflammatory and anticancer activity. Bioorganic Chemistry, 133, 106406. (Cited by 12)

5. Kaur, G., Kaur, M., & Bansal, M. (2021). New insights of structural activity relationship of curcumin and correlating their efficacy in anticancer studies with some other similar molecules. American Journal of Cancer Research, 11(8), 3755–3769. (Cited by 9)

 

Jing Nie | Medicinal Chemistry | Best Researcher Award

Ms. Jing Nie | Medicinal Chemistry | Best Researcher Award

Ms. Jing Nie | Shandong Second Provincial General Hospital | China

Ms. Jing Nie serves as the Head of Scientific Research in the Department of Pharmacy at Shandong Second Provincial General Hospital and holds the position of Associate Chief Pharmacist. She actively contributes to the advancement of pharmaceutical sciences through her leadership roles in various professional committees, including the Shandong Provincial Hospital Association’s Digital and Intelligent Pharmacy Committee, the Pediatric Rational Drug Use Committee of the Shandong Pharmacists Association, and the Otolaryngology Pharmacy Committee of the Shandong Pharmaceutical Society. She is also a core member of the Rheumatology Committee of the Jinan Association of Integrated Traditional Chinese and Western Medicine, the Antitumor Drug Committee of the Shandong Pharmaceutical Society, the Tumor Pharmacy Branch of the Shandong Anti-Cancer Association, and the Internet Plus Pharmacy Services Committee. Her research focuses on hospital pharmacy, artificial intelligence, pharmacoeconomics, and antitumor drug development. She has published extensively, secured patents, developed software, and led multiple provincial and collaborative projects while contributing to numerous national-level studies.

Publication Profile

Scopus

Education

Ms. Jing Nie earned her doctoral degree in pharmacy, equipping her with a strong academic foundation to contribute to both scientific research and clinical pharmacy practice. Her education combined rigorous theoretical learning with extensive research experience, allowing her to specialize in the integration of hospital pharmacy with advanced technologies such as artificial intelligence and pharmacoeconomics. During her doctoral training, she focused on evidence-based approaches to optimize drug therapy and explored the mechanisms and applications of antitumor drugs. Her academic journey not only strengthened her technical expertise but also instilled in her a deep commitment to innovation, patient safety, and rational drug use. She has built upon her formal education through continuous professional development, actively engaging with academic societies, conferences, and specialized committees that broaden her knowledge and keep her at the forefront of evolving pharmaceutical sciences. Her educational background remains the cornerstone of her contributions to research and practice.

Experience

Ms. Jing Nie has extensive professional experience as the Head of Scientific Research in the Department of Pharmacy at Shandong Second Provincial General Hospital, where she also serves as Associate Chief Pharmacist. Her experience includes leadership and active participation in multiple prestigious committees, such as those dedicated to digital pharmacy, rational pediatric drug use, otolaryngology pharmacy, rheumatology, and oncology. She has played a key role in advancing pharmaceutical sciences by bridging hospital pharmacy with innovative fields like artificial intelligence and pharmacoeconomics. Her experience is further reflected in her strong publication record, where she has authored and co-authored more than twenty scientific papers, many in high-impact journals. She has successfully applied her expertise to provincial-level projects, cross-disciplinary collaborations, and has contributed significantly to national-level studies. In addition, her practical work includes obtaining multiple patents and software copyrights, reinforcing her ability to translate scientific innovation into practical applications that benefit patients and the healthcare system.

Research Focus

Ms. Jing Nie’s research focus lies at the intersection of pharmaceutical sciences, oncology, and innovative therapeutic strategies. Her work on the advances of HDAC dual inhibitors in breast cancer treatment highlights her commitment to exploring novel drug mechanisms and targeted therapies in oncology. By investigating epigenetic regulation through HDAC inhibition, she contributes to the development of more effective treatments for breast cancer patients, bridging basic research with clinical applications. Beyond oncology, her broader focus includes hospital pharmacy, pharmacoeconomics, artificial intelligence in drug management, and rational drug use. This multidisciplinary approach allows her to integrate clinical practice with cutting-edge research, addressing both the economic and therapeutic aspects of patient care. Her emphasis on anti-tumor drug development, combined with her role in scientific committees and leadership positions, reflects a holistic vision of improving healthcare outcomes through innovation, collaboration, and translational research. Ms. Nie’s focus is well aligned with advancing precision medicine and modern pharmacy.

Publication Top Notes

Advances of HDAC dual inhibitors in breast cancer treatment

Conclusion

Ms. Jing Nie is highly suitable for the Research for Best Researcher Award, given her impactful contributions to pharmaceutical sciences, leadership roles, and innovation in anti-tumor drug research and artificial intelligence. With strategic international engagement and clinical translation of her work, she has the potential to become a globally recognized leader in hospital pharmacy research.

SooHo Yeo | Medicinal Chemistry | Best Researcher Award

Dr. SooHo Yeo | Medicinal Chemistry | Best Researcher Award

Research Professor from Yonsei University College of Pharmacy | South Korea

Dr. SooHo Yeo is a distinguished pharmaceutical researcher specializing in pharmaceutics, nanomedicine, and photodynamic cancer therapy. He earned his M.S./Ph.D. from the College of Pharmacy at Chung-Ang University, Seoul, Korea, with a dissertation focused on artificial skin formulation for the topical delivery of adenosine. Currently serving as a Research Professor at Yonsei University, he previously held a similar position at INJE University’s Department of Nanoscience and Engineering. Dr. Yeo’s expertise spans nano/micro-particle drug delivery, solid lipid nanoparticles, liposomes, and cosmetic dermatology. His work includes in vitro toxicology, pharmacokinetic/pharmacodynamic analysis, and OECD-guideline-based skin testing. He has published extensively in top-tier journals such as ACS Omega, Scientific Reports, International Journal of Pharmaceutics, and Pharmaceutics, with research focused on enhancing anticancer efficacy through innovative nanoparticle systems. Dr. Yeo is widely recognized for his interdisciplinary contributions that merge pharmaceutical sciences, biomedical engineering, and clinical research.

Publication Profile

Orcid

Academic Background

Dr. SooHo Yeo earned his M.S./Ph.D. degree from the prestigious College of Pharmacy at Chung-Ang University, located in Seoul, Korea. His academic journey reflects a strong foundation in pharmaceutical sciences, with a focus on drug delivery systems and dermal formulations. His doctoral research, titled “Artificial Skin Formulation for Topical Delivery of Adenosine,” showcases his early commitment to developing innovative therapeutic approaches using transdermal delivery platforms. The dissertation centered on the design and optimization of artificial skin systems to enhance the bioavailability and therapeutic impact of adenosine, a bioactive compound with potential in cosmetic and pharmaceutical applications. This research not only demonstrated Dr. Yeo’s technical expertise in pharmaceutics and cosmeceutics but also laid the groundwork for his later contributions to nanomedicine and photodynamic therapy. His education at Chung-Ang University provided a solid interdisciplinary foundation that continues to shape his impactful research in pharmaceutical innovation.

Professional Experience

Dr. SooHo Yeo has held prominent research positions that underscore his expertise in pharmaceutical sciences and nanotechnology. he has been serving as a Research Professor at the College of Pharmacy, Yonsei University, Incheon, Korea, where he contributes to cutting-edge research in drug delivery systems, photodynamic therapy, and cosmetic formulation development. Prior to this role, Dr. Yeo worked as a Research Professor in the Department of Nanoscience and Engineering at INJE University in Gimhae, Korea. During his tenure at INJE University, he focused on advanced nanomaterials for biomedical applications, integrating nanoscience with pharmacological innovation. His work at both institutions reflects a consistent dedication to interdisciplinary research, bridging pharmaceutical development with nanotechnology and bioengineering. Dr. Yeo’s professional experience highlights his active role in advancing therapeutic strategies through nanomedicine and solidifies his reputation as a leading figure in pharmaceutical and cosmetic research in South Korea.

Research Focus

Dr. SooHo Yeo’s research is firmly rooted in pharmaceutical sciences, with a specialized focus on nanomedicine, drug delivery systems, and photodynamic therapy for cancer treatment. His work centers on the development of advanced nanoformulations such as solid lipid nanoparticles, nanostructured lipid carriers, and lipid-based vesicles to enhance the therapeutic efficacy of anti-cancer agents like purpurin derivatives, doxorubicin, aspirin, and curcumin. A major theme in his research is topical and transdermal delivery systems using biocompatible polymers like hydroxypropyl methylcellulose for treating skin cancer. He also explores emulsion gels, pH-responsive nanocarriers, and cosmeceutical applications to treat or prevent conditions like postoperative adhesions and dermatological issues. His studies include in vitro and in vivo evaluations, highlighting a strong translational approach. Through consistent contributions to peer-reviewed journals, Dr. Yeo has positioned himself at the forefront of targeted drug delivery, phototherapy, and pharmaceutical nanotechnology aimed at improving patient outcomes in oncology and dermatology.

Publication Top Notes

  • Preparation and evaluation of hydroxypropyl methylcellulose‐based film incorporated with aspirin‐loaded solid lipid nanoparticles to treat skin cancer
    Year: 2025

  • Development of nanostructured lipid carriers loaded with purpurin-18 N propargylimide methyl ester to improve photodynamic therapy
    Year: 2025

  • Application of PLGA nanoparticles to photodynamic cancer therapy by encapsulating Purpurin-18-N-hydroxylimide methyl ester
    Year: 2025

  • A Celecoxib-Loaded Emulsion Gel for Enhanced Drug Delivery and Prevention of Postoperative Adhesion
    Year: 2025

  • Encapsulation of synthesized purpurin-18-N-aminoimide methyl ester in lipid nanovesicles for use as agents in photodynamic cancer therapy
    Year: 2025

Conclusion

Dr. SooHo Yeo is a highly qualified candidate for the Research for Best Researcher Award. His cutting-edge work in nanoparticle-based drug delivery systems, photodynamic therapy, and cosmeceutical formulations, combined with an impressive publication record and solid research positions, positions him as a frontrunner in pharmaceutical sciences. While metrics on citations and translational outcomes could further bolster his candidacy, his depth of expertise, innovation, and interdisciplinary application make him strongly suitable for this award.

 

Ahmed M. Elewa | Chemistry | Best Researcher Award

Prof. Ahmed M. Elewa | Chemistry | Best Researcher Award

Prof. Ahmed M. Elewa | Egyptian Atomic Energy Authority | Egypt

Prof. Ahmed M. Elewa is an accomplished chemist specializing in inorganic, organic, and materials chemistry with expertise in reticular synthesis, metal oxides, CMPs, COFs, and photocatalytic hydrogen production. He serves as an Assistant Professor at the Nuclear Chemistry Department, Atomic Energy Authority of Egypt. Holding a Ph.D. in Chemical Engineering from National Tsing Hua University (Taiwan), he has published extensively on water treatment, photocatalysis, and advanced materials. Prof. Elewa has earned multiple awards, contributed as an editor and reviewer for renowned journals, and participated in numerous international workshops and conferences. He also holds a U.S. patent on COF synthesis and continues to advance energy and environmental technologies.

Publication Profile

Google Scholar

Professional Experience

Prof. Ahmed M. Elewa has an extensive background in nuclear chemistry and industrial research, with a career spanning over a decade. Since 2024, he has served as an Assistant Professor, Researcher, and Chemist at the Nuclear Chemistry Department, Radio Isotopes Productions and Radiation Sources Division, Hot Laboratories Center, Atomic Energy Authority (AEA) of Egypt. His current work focuses on reticular synthesis and advanced materials chemistry, where he conducts research on radioactive waste treatment and innovative material synthesis, and has developed novel techniques for radioisotope separation. Prior to this, from 2013 to 2019, he worked at the same division within AEA, concentrating on similar research themes, which laid a strong foundation for his advanced investigations. Earlier in his career, from 2011 to 2013, Prof. Elewa gained industrial experience at El-Midani Company for Man-Made Fibers in Obour City, Egypt, where he contributed to chemical processing and product development in synthetic fiber manufacturing.

Educational Background

Prof. Ahmed M. Elewa possesses a robust and multidisciplinary academic foundation in chemistry and related sciences. He earned his Ph.D. in Chemical Engineering from the prestigious National Tsing Hua University (NTHU) in Taiwan between March 2019 and December 2022, where he specialized in advanced materials and energy-related chemical processes. Prior to his doctoral studies, he completed a Master’s degree in Inorganic and Analytical Chemistry at Ain Shams University, Egypt, from April 2014 to September 2016. He also holds a Diploma in Physiology and Biochemistry from the Faculty of Science, Suez Canal University, obtained between September 2013 and May 2014, enriching his interdisciplinary expertise. Additionally, he pursued a Pre-master’s degree in Inorganic and Analytical Chemistry at Ain Shams University from September 2012 to September 2013. His academic journey began with a Bachelor’s degree in Chemistry from Al Azhar University, Egypt, where he studied from September 2007 to May 2011, laying the groundwork for his scientific career.

Honors and Awards

Prof. Ahmed M. Elewa has been recognized for his outstanding academic and research contributions with notable accolades. In 2022, he received the prestigious Postgraduate Students Publishing Competition Award, honoring his excellence in scientific publishing and impactful contributions to the field of chemical engineering and materials science. This award highlights his ability to produce high-quality, peer-reviewed research that advances knowledge in his domain. In the same year, he was also honored with the SEED Conference Oral Competition Award, which acknowledged his exceptional presentation skills, scientific insight, and ability to effectively communicate complex research findings at a competitive international conference. These awards reflect Prof. Elewa’s dedication to advancing science through both written and spoken platforms and mark him as a leading researcher with a strong commitment to academic excellence and innovation in the fields of materials chemistry, environmental applications, and energy-related technologies.

Research Focus

Dr. Ahmed M. Elewa’s research is at the forefront of photocatalysis, covalent organic frameworks (COFs), and polymer chemistry, with a strong emphasis on visible-light-driven hydrogen evolution. His most cited works demonstrate innovations in dual-function fluorescent COFs, sulfur-doped and pyrene-containing microporous polymers, and donor-acceptor systems designed for efficient solar energy harvesting and water splitting. Elewa’s contributions to the development of metal-free photocatalysts, heterostructured composites, and high-crystallinity COFs are instrumental in advancing green hydrogen production technologies. Furthermore, his collaborative studies have explored adsorptive removal of radionuclides, iodine capture, and organic dye degradation, reinforcing his commitment to environmental remediation. His work spans across materials science, coordination chemistry, environmental catalysis, and energy conversion, making him a notable contributor to sustainable energy solutions. Through a multidisciplinary approach combining synthesis, structural design, and performance evaluation, Dr. Elewa is shaping the future of clean energy and environmental nanomaterials.

Publication Top Notes

1. Dual‐Function Fluorescent Covalent Organic Frameworks: HCl Sensing and Photocatalytic H₂ Evolution from Water
Citation: 148
Year: 2020

2. Visible-light-driven hydrogen evolution using nitrogen-doped carbon quantum dot-implanted polymer dots as metal-free photocatalysts
Citation: 125
Year: 2021

3. Pyrene-containing conjugated organic microporous polymers for photocatalytic hydrogen evolution from water
Citation: 109
Year: 2021

4. Recent advances in metal/covalent organic frameworks based materials: Their synthesis, structure design and potential applications for hydrogen production
Citation: 104
Year: 2023

5. Donor-acceptor carbazole-based conjugated microporous polymers as photocatalysts for visible-light-driven H₂ and O₂ evolution from water splitting
Citation: 91
Year: 2022

6. Sulfur-doped triazine-conjugated microporous polymers for achieving the robust visible-light-driven hydrogen evolution
Citation: 91
Year: 2021

Conclusion

Prof. Ahmed M. Elewa demonstrates a well-rounded and exceptional profile that aligns closely with the ideals of the Best Researcher Award. His multidisciplinary expertise, significant scientific output, technological innovations, and editorial contributions firmly establish him as a leader in his field. With minor additions like citation analysis and evidence of international leadership, his candidacy would be further solidified. As it stands, he is highly deserving and a strong contender for the award.

 

 

Seyed Mohammad Vahdat | Organic Chemistry | Best Researcher Award

Assoc. Prof. Dr. Seyed Mohammad Vahdat | Organic Chemistry | Best Researcher Award

Assoc. Prof. Dr. Seyed Mohammad Vahdat at Department of Chemistry, Am.c. Islamic Azad University, Amol, Iran

Dr. Seyed Mohammad Vahdat is an Associate Professor of Organic Chemistry at the Ayatollah Amoli International Branch, Islamic Azad University, Iran. With a Ph.D. in Organic Chemistry from the University of Mazandaran, his research spans medicinal chemistry, nanocatalysts, drug delivery, and phytochemistry. He has published extensively, supervised over 100 students, and holds a national patent. Dr. Vahdat serves on editorial boards of several journals and is an active member of multiple scientific societies. He has received multiple “Best Researcher” awards and held various academic leadership roles, reflecting his commitment to advancing research, education, and scientific innovation.

Academic Profile

Orcid

Educational Background

Dr. Seyed Mohammad Vahdat holds a strong academic foundation in chemistry, having earned his Ph.D. and M.Sc. in Organic Chemistry from the University of Mazandaran, Babolsar, Iran. He began his academic journey with a B.Sc. in Applied Chemistry from the same institution. Over the years, his educational background has supported a prolific research career in fields such as medicinal chemistry, nanocatalysts, and phytochemistry. His deep-rooted knowledge and academic training have enabled him to supervise over 100 students and contribute significantly to scientific research and innovation, establishing him as a respected figure in Iran’s academic and research community.

Professional Experience

Dr. Seyed Mohammad Vahdat has over two decades of professional experience in academia and research. Currently serving as an Associate Professor of Organic Chemistry at the Ayatollah Amoli International Branch, Islamic Azad University, Iran, he has held key academic leadership positions, including Chancellor, Vice-Chancellor for Research and Technology, and Head of various departments. His research expertise includes medicinal chemistry, nanocatalysts, and drug delivery. He has actively participated in national and international conferences, edited scientific journals, and reviewed for multiple high-impact publications. Dr. Vahdat’s extensive professional service reflects his dedication to academic excellence and scientific advancement.

Research Focus

Dr. Seyed Mohammad Vahdat’s research primarily centers on organic chemistry with a strong emphasis on medicinal chemistry, nanocatalysts, drug delivery systems, green synthesis, and phytochemistry. His work integrates advanced chemical methodologies with applications in sustainable and health-related technologies. He has contributed to the development of novel synthetic routes, including the use of metal and metal oxide nanoparticles and ionic liquid catalysts. With numerous publications in reputable international journals and a registered patent, his research addresses both fundamental and applied challenges in modern chemistry. Dr. Vahdat’s innovative approach continues to impact scientific progress and interdisciplinary collaboration.

Publication Top Notes

Reactions and Catalytic Applications of Metal and Metal Oxide Nanoparticles in Organic and Inorganic Chemistry

2025

New strategy to 1,8‑dioxo‑decahydroacridine derivatives using SnO₂ nanoparticles via one‑pot Knoevenagel condensation and Michael addition mechanisms

2024

Zeolitic imidazolate framework/graphene oxide hybrid nanosheets functionalized chitosan… for Cu(II) adsorption

2024

Conclusion

Dr. Seyed Mohammad Vahdat is a distinguished Associate Professor of Organic Chemistry at the Ayatollah Amoli International Branch, Islamic Azad University, Iran, with over two decades of academic and research excellence. He holds a Ph.D. in Organic Chemistry and has made significant contributions to medicinal chemistry, nanocatalysts, drug delivery, green synthesis, and phytochemistry. With more than 100 student supervisions, numerous international publications, a registered patent, and extensive editorial and review roles, he has earned multiple “Best Researcher” awards. While expanding his visibility in top-tier journals and global collaborations could enhance his international impact, his credentials, innovation, and leadership make him a strong contender for the Best Researcher Award